GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CollPlant Biotechnologies Ltd (FRA:CPT) » Definitions » Cyclically Adjusted PS Ratio

CollPlant Biotechnologies (FRA:CPT) Cyclically Adjusted PS Ratio : 2.00 (As of May. 22, 2025)


View and export this data going back to 2021. Start your Free Trial

What is CollPlant Biotechnologies Cyclically Adjusted PS Ratio?

As of today (2025-05-22), CollPlant Biotechnologies's current share price is €1.22. CollPlant Biotechnologies's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 was €0.61. CollPlant Biotechnologies's Cyclically Adjusted PS Ratio for today is 2.00.

The historical rank and industry rank for CollPlant Biotechnologies's Cyclically Adjusted PS Ratio or its related term are showing as below:

FRA:CPT' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.37   Med: 6.44   Max: 8.61
Current: 2.61

During the past years, CollPlant Biotechnologies's highest Cyclically Adjusted PS Ratio was 8.61. The lowest was 2.37. And the median was 6.44.

FRA:CPT's Cyclically Adjusted PS Ratio is ranked better than
67.27% of 501 companies
in the Biotechnology industry
Industry Median: 5.35 vs FRA:CPT: 2.61

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

CollPlant Biotechnologies's adjusted revenue per share data for the three months ended in Dec. 2024 was €0.014. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €0.61 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


CollPlant Biotechnologies Cyclically Adjusted PS Ratio Historical Data

The historical data trend for CollPlant Biotechnologies's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CollPlant Biotechnologies Cyclically Adjusted PS Ratio Chart

CollPlant Biotechnologies Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 8.18 4.94

CollPlant Biotechnologies Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.18 6.97 6.64 - 4.94

Competitive Comparison of CollPlant Biotechnologies's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, CollPlant Biotechnologies's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CollPlant Biotechnologies's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CollPlant Biotechnologies's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where CollPlant Biotechnologies's Cyclically Adjusted PS Ratio falls into.


;
;

CollPlant Biotechnologies Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

CollPlant Biotechnologies's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=1.22/0.61
=2.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CollPlant Biotechnologies's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 is calculated as:

For example, CollPlant Biotechnologies's adjusted Revenue per Share data for the three months ended in Dec. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.014/133.1571*133.1571
=0.014

Current CPI (Dec. 2024) = 133.1571.

CollPlant Biotechnologies Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201503 0.000 99.621 0.000
201506 0.000 100.684 0.000
201509 0.000 100.392 0.000
201512 0.000 99.792 0.000
201603 0.000 100.470 0.000
201606 0.000 101.688 0.000
201609 0.000 101.861 0.000
201612 0.000 101.863 0.000
201703 0.001 102.862 0.001
201706 0.000 103.349 0.000
201709 0.000 104.136 0.000
201712 0.066 104.011 0.084
201803 0.001 105.290 0.001
201806 0.001 106.317 0.001
201809 0.042 106.507 0.053
201812 0.826 105.998 1.038
201903 0.113 107.251 0.140
201906 0.115 108.070 0.142
201909 0.132 108.329 0.162
201912 0.066 108.420 0.081
202003 0.083 108.902 0.101
202006 0.105 108.767 0.129
202009 0.356 109.815 0.432
202012 0.066 109.897 0.080
202103 1.061 111.754 1.264
202106 0.056 114.631 0.065
202109 0.011 115.734 0.013
202112 0.025 117.630 0.028
202203 0.006 121.301 0.007
202206 0.006 125.017 0.006
202209 0.010 125.227 0.011
202212 0.005 125.222 0.005
202303 0.036 127.348 0.038
202306 0.798 128.729 0.825
202309 0.003 129.860 0.003
202312 0.024 129.419 0.025
202403 0.008 131.776 0.008
202406 0.020 132.554 0.020
202409 0.000 133.029 0.000
202412 0.014 133.157 0.014

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


CollPlant Biotechnologies  (FRA:CPT) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


CollPlant Biotechnologies Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of CollPlant Biotechnologies's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


CollPlant Biotechnologies Business Description

Traded in Other Exchanges
Address
4 Oppenheimer Street, P.O. Box 4132, Weizmann Science Park, Rehovot, ISR, 7670104
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.